By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ogeda 

47 Rue Adrienne Bolland

  Gosselies  6041  Belgium
Phone: 32-71-348- 500 Fax: n/a


SEARCH JOBS

Ogeda is a Belgium-based, privately owned clinical-stage drug discovery company that invents and develops small molecule drug candidates targeting GPCRs. Ogeda’s orally-available and proprietary lead drug candidate fezolinetant (ESN364) is currently in Phase II clinical development for the treatment of women’s health disorders. Ogeda has additional small molecules targeting GPCRs in preclinical development in multiple therapeutic areas including inflammatory and autoimmune diseases. Ogeda is backed by leading investors, including Vesalius Biocapital, Fund+ and SRIW.


Key Statistics


Email: info@ogeda.com
Ownership: Private

Web Site: Ogeda
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->